NewcelX Ltd.
- NCEL
- NASDAQ
- Biotechnology
- Neurology/CNS Therapies
- Cell-Based Therapeutics
$2.63
Today +5.20%Quote Oct 19, 2026, 08:00 PM UTC
−16.51%over the last month
Max drawdown −20.6%From 1-month high −16.5%3 months −31.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About NewcelX
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
11
Market value
$12.6M
Quote Oct 19
Floor
$2.49
5.4% below price
Resistance
$2.71
3.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NCELPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free